| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/08/1999 | WO1999016455A1 Mannose receptor bearing cell line and antigen composition |
| 04/08/1999 | WO1999016318A1 Reduced antigenic cells and uses therefor |
| 04/08/1999 | WO1999004026A3 Lentiviral vectors |
| 04/08/1999 | WO1999003508A3 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 04/08/1999 | WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/08/1999 | WO1998049321A8 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 04/08/1999 | CA2320156A1 Reduced antigenic cells and uses therefor |
| 04/08/1999 | CA2304206A1 Stimulation of hematopoietic cells in vitro |
| 04/08/1999 | CA2304007A1 Generation of hematopoietic cells from multipotent neural stem cells |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/07/1999 | EP0906951A2 Storage of materials |
| 04/07/1999 | EP0906441A1 Antitumour cellular compositions expressing at least three transgenes |
| 04/07/1999 | EP0906428A1 Use of interleukin-10 to produce a population of suppressor cells |
| 04/07/1999 | EP0906415A1 Regeneration and augmentation of bone using mesenchymal stem cells |
| 04/07/1999 | EP0689447B1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 04/07/1999 | EP0662857B1 Systems and methods for reducing leukocytes in cellular products |
| 04/07/1999 | CN1213326A Filtration of plasma mixtures using cellulose-based filter aids |
| 04/07/1999 | CN1213317A Method and apparatus for inactivating contaminants in biological fluid |
| 04/07/1999 | CN1213311A Method of using emu oil and active peactions thereof as insect repellant |
| 04/07/1999 | CN1213310A Product of heat treatment of uronic acid, food, drink or drug including the product |
| 04/07/1999 | CN1212886A Pill for treating hepatopathy |
| 04/07/1999 | CN1212885A Traditional Chinese medicine capsule for treating thrombophlebitis |
| 04/07/1999 | CN1212884A Method for preparing piles medicament |
| 04/07/1999 | CN1042833C Process for preparing growth factor of human nerve by embryonic down or decidual |
| 04/07/1999 | CN1042799C Analgetic plaster for promoting blood circulation and removing blood stasis |
| 04/07/1999 | CN1042798C Method for preparation of oral liquid for treating ophthalmology disease |
| 04/07/1999 | CN1042797C Antibiosis and antiviral oral liquor |
| 04/06/1999 | US5891844 Compositions for treating IRDS and ARDS with a combination of a Glucocorticosteroid and a lung surfactant, and their use |
| 04/06/1999 | US5891680 Dna molecule encoding an active il-12 fusion protein with at least two polypeptide monomers linked by heterologous polypeptide linker; stimulates ifn-alpha production, enhances antitumor immunity and cell mediated immunity |
| 04/06/1999 | US5891678 Isolated polynucleotide encoding bacterial enzyme involved in mediating protein secretion; treatment of invasive infections and toxigenic diseases; antibiotic screening and development |
| 04/06/1999 | US5891670 Tetracycline resistance protein |
| 04/06/1999 | US5891653 Immunomodulators for tissue transplants; contacting antigen presenting cells with purified stress proteins bound to an antigen; in vitro treatment of allograft, xenografts rejections in humans and animals |
| 04/06/1999 | US5891464 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it |
| 04/06/1999 | US5891432 Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same |
| 04/06/1999 | CA2221433A1 Selective expansion of target cell populations |
| 04/06/1999 | CA2064228C Lyophilized and reconstituted cell compositions |
| 04/01/1999 | WO1999015684A2 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 04/01/1999 | WO1999015683A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 04/01/1999 | WO1999015637A1 Fibrin microbeads and uses thereof |
| 04/01/1999 | WO1999015557A1 Malaria polypeptides |
| 04/01/1999 | WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 04/01/1999 | WO1999015199A1 Antigen presenting mesenchymal stem cells |
| 04/01/1999 | WO1999015190A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 04/01/1999 | WO1999014996A2 Method of analyzing nonstationary data |
| 04/01/1999 | WO1998054301A3 Transplants for myocardial scars and method and cellular preparations therefor |
| 04/01/1999 | WO1998053075A3 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 04/01/1999 | WO1998051787A3 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 04/01/1999 | WO1998051660A9 Methods and compositions for the selective modification of nucleic acids |
| 04/01/1999 | WO1998044874A9 Neocartilage and methods of use |
| 04/01/1999 | WO1998039464A8 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/01/1999 | WO1998014592A3 Telomerase reverse transcriptase |
| 04/01/1999 | DE19842785A1 Preparation of porous material with a hydrophilic and porous surface with functional ligands |
| 04/01/1999 | CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof |
| 04/01/1999 | CA2304384A1 Fibrin microbeads and uses thereof |
| 04/01/1999 | CA2304268A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 04/01/1999 | CA2304259A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 04/01/1999 | CA2303663A1 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 04/01/1999 | CA2302339A1 Antigen presenting mesenchymal stem cells |
| 03/31/1999 | EP0905254A2 DNA vector associated with biocompatible low molecular weight polyethyleneimines |
| 03/31/1999 | EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it |
| 03/31/1999 | EP0905245A1 Staphylococcal polypeptides Spo0J1 |
| 03/31/1999 | EP0905233A2 Staphylococcus aureus trigger factor |
| 03/31/1999 | EP0904785A1 Protein C inhibitor against hypercoagulation |
| 03/31/1999 | EP0904784A1 Probiotic nutritional preparation |
| 03/31/1999 | EP0904694A1 Antimicrobial agents for eucaryotic microorganisms and methods of growth suppression of eucaryotic microorganisms using these agents |
| 03/31/1999 | EP0904374A1 Processed polypeptides with il-16 activity, process for preparing the same and their use |
| 03/31/1999 | EP0904373A1 Targeted delivery of genes encoding interferon |
| 03/31/1999 | EP0904281A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE |
| 03/31/1999 | EP0904280A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE |
| 03/31/1999 | EP0904104A1 Novel compounds |
| 03/31/1999 | EP0904103A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE GLUTAMYL tRNA SYNTHETASE FAMILY |
| 03/31/1999 | EP0904102A1 Milk of transgenic animals containing human alpha 1-antitrypsin and use of human alpha 1-antitrypsin to treat bile acid related diseases |
| 03/31/1999 | EP0904091A1 Adhesion inhibitors, preparation comprising them and method for producing them |
| 03/31/1999 | EP0904090A1 Egg anti-inflammatory composition, method of isolation and use |
| 03/31/1999 | EP0684867B1 Blood filter and method of its manufacturing |
| 03/31/1999 | EP0684866B1 Method of estimating the average fiber diameter of different filtration media |
| 03/31/1999 | CN1212723A Disinfecting compositions and process for disinfecting surfaces |
| 03/31/1999 | CN1212162A High efficiency ointment for curing beri-beri (tinea pedis) |
| 03/31/1999 | CN1212161A Anti-radioactivity fibration drug |
| 03/31/1999 | CN1212160A Baoyuan Fuchun Yunqi plaster |
| 03/31/1999 | CN1212159A Asteriscus Pseudosciaenae pill and instant powder |
| 03/31/1999 | CN1212153A Fengruyou oil for improving human breast regrowth |
| 03/31/1999 | CN1212152A Preparation of external use eyedrops for curing eye chronic disease and productive process thereof |
| 03/31/1999 | CN1212140A Wood frog ovum composition and its preparation capable of improving calcium absorption function |
| 03/31/1999 | CN1212132A Tartaric acid nutritious honey capable of balancing blood pressure |
| 03/31/1999 | CN1042733C Use of jackfruit seed agglutinin affinity chromatographic column |
| 03/31/1999 | CN1042698C Method for preparation of traumatic analgesic plaster |
| 03/30/1999 | US5889175 Nucleic acids encoding HIV-1 trans-dominant mutants and their use to abrogate HIV-1 viral replication |
| 03/30/1999 | US5889156 TNF deletion muteins |
| 03/30/1999 | US5889143 Evaluation and treatment of patients with progressive immunosuppression |
| 03/30/1999 | US5888816 Cell cultures of and cell culturing method for nontransformed pancreatic, thyroid, and parathyroid cells |
| 03/30/1999 | US5888791 Metabolites in culture |
| 03/30/1999 | US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells |
| 03/30/1999 | US5888705 Pancreatic cells to treat type 1 diabetes mellitus. the invention relates to the use of a human cytokine, hepatocyte growth factor/scatter factor (?hgf/sf?). |
| 03/30/1999 | US5888552 Anti-cancer therapeutic compositions containing whey protein concentrate |
| 03/30/1999 | US5888551 Stimulating hair growth by applying a medium containing hair growth-stimulating activity or factors obtained from a cell culture of human mononuclear cells |
| 03/30/1999 | US5888514 Natural composition for treating bone or joint inflammation |
| 03/30/1999 | US5888499 Containing myeloblasts |
| 03/30/1999 | US5888497 Encapsulated cells |
| 03/30/1999 | US5888409 Methods for cell isolation and collection |